Literature DB >> 1587407

Mechanism of gastric mucosal damage induced by ammonia.

M Tsujii1, S Kawano, S Tsuji, H Fusamoto, T Kamada, N Sato.   

Abstract

The mechanism for Helicobacter pylori-induced gastric mucosal injury remains obscure. H. pylori has high urease activity to produce ammonia from urea in the stomach. In this study, the effects of ammonia on (a) gastric mucosal integrity, (b) gastric mucosal hemodynamics, (c) mucosal cellular viability, (d) mitochondrial respiration, and (e) energy metabolism of gastric mucosal were investigated. Ammonia (pH 10.3) at concentrations of greater than 125 mmol/L caused acute macroscopic gastric mucosal lesions in a dose-dependent manner, whereas glycine-NaOH buffer (pH 10.3) or ammonium chloride (pH 4.5) did not. The decrease in energy charge preceded the occurrence of gastric mucosal lesions, but ammonia caused no change in mucosal hemodynamics. Oxygen consumption of isolated cells and mitochondria of gastric mucosa was inhibited by ammonia dose-dependently. The present results indicate that ammonia impairs mitochondrial and cellular respiration and energy metabolism and that ammonia decreases mucosal cell viability, leading subsequently to mucosal damage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587407     DOI: 10.1016/0016-5085(92)90309-m

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  20 in total

1.  Study of T-lymphocyte subsets, nitric oxide, hexosamine and Helicobacter pylori infection in patients with chronic gastric diseases.

Authors:  Hui Zhang; Shu-Lin Jiang; Xi-Xian Yao
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

2.  Ammonia, hydrogen peroxide, and monochloramine retard gastric epithelial restoration in rabbit cultured cell model.

Authors:  K Sato; S Watanabe; T Yoshizawa; M Hirose; T Murai; N Sato
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

3.  Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model.

Authors:  N Sawai; M Kita; T Kodama; T Tanahashi; Y Yamaoka; Y Tagawa; Y Iwakura; J Imanishi
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  Ammonia as an accelerator of tumor necrosis factor alpha-induced apoptosis of gastric epithelial cells in Helicobacter pylori infection.

Authors:  M Igarashi; Y Kitada; H Yoshiyama; A Takagi; T Miwa; Y Koga
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

5.  Studies on purine enzymes in experimental colitis.

Authors:  F M Al-Awadi; I Khan
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

Review 6.  Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms.

Authors:  Shingo Tsuji; Masahiko Tsujii; Hiroaki Murata; Tsutomu Nishida; Masato Komori; Masakazu Yasumaru; Shuji Ishii; Yoshiaki Sasayama; Sunao Kawano; Norio Hayashi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

7.  Effects of Helicobacter pylori infection on gastric mucosal defense factors in Japanese monkeys.

Authors:  K Fujiyama; T Fujioka; K Murakami; M Nasu
Journal:  J Gastroenterol       Date:  1995-08       Impact factor: 7.527

8.  Effect of chronic duodenal ulceration and its treatment with lanzoprazole or sucralfate on gastroduodenal mucosal protein turnover and TGF-alpha, bFGF, and EGF receptor expression in humans.

Authors:  T Zhang; S J O'Keefe; T Winter; I N Marks; J Ogden
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

9.  Mucosal ulcerogenic action of monochloramine in rat stomachs: effects of polaprezinc and sucralfate.

Authors:  S Kato; H Nishiwaki; A Konaka; K Takeuchi
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

10.  Bacterial activity of a new antiulcer agent, ecabet sodium, against Helicobacter pylori under acidic conditions.

Authors:  K Shibata; Y Ito; A Hongo; A Yasoshima; T Endo; M Ohashi
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.